Quick Answer
Kraig Biocraft Laboratories, Inc. reported Cash and Equivalents of $1.79 million for fiscal year 2025.
Kraig Biocraft Laboratories, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.79M | +165.9% |
| 2024 | $673.3K | -73.6% |
| 2023 | $2.55M | -33.9% |
| 2022 | $3.86M | +28101.2% |
| 2018 | $13.7K | -24.5% |
| 2017 | $18.1K | -93.9% |
| 2016 | $298.9K | +25.5% |
| 2015 | $238.2K | -51.9% |
| 2014 | $495.0K | +67.6% |
| 2013 | $295.4K | +449.2% |
| 2012 | $53.8K | -72.5% |
| 2011 | $195.4K | +111.8% |
| 2010 | $92.2K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.57M | +31.6% | +99.3% |
| June 30, 2025 | $785.5K | -48.4% | +97.8% |
| March 31, 2025 | $397.0K | -80.6% | -41.0% |
| December 31, 2024 | $673.3K | -73.6% | -43.4% |
| September 30, 2024 | $1.19M | -58.9% | -21.8% |
| June 30, 2024 | $1.52M | — | -25.7% |
| March 31, 2024 | $2.05M | — | -19.8% |
| December 31, 2023 | $2.55M | -33.9% | -11.8% |
- Kraig Biocraft Laboratories, Inc. showed an increase of +165.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, Kraig Biocraft Laboratories, Inc.’s cash and equivalents has grown by 1840.8% (from $92.2 thousand to $1.79 million).
- The most recent figure is from Kraig Biocraft Laboratories, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: